About US

Our Mission

At VisionAir Solutions, we acknowledge that each patient is unique. This is why we believe that reimagining the airway stent is crucial for the future of interventional airway treatment. Our company strives to work with leading pulmonologists to deliver the essential tools that will allow them to meet the needs of any individual.

About Us

VisionAir Solutions

Our Mission


VisionAir Solutions is a leader in personalized pulmonary implants.  We manufacture patient-specific stents by combining the latest 3D-printing technology with traditional medical-grade silicone injection. These revolutionary "3D Stents" are designed for each patient by their treating pulmonologist in our revolutionary cloud-based software platform.

Our Team

The VisionAir Team is a nimble cross-functional group of engineers and designers who are highly experienced in developing complex medical device systems.  The team has successfully brought two patient-specific systems to market across orthopedics and pulmonology.

Clinical Engineering Manager

Adrianna Baiera

Software Engineering Manager

Brian Beckrest

UX/UI Designer

Tyler Blackiston

Infrastructure Engineer

Greg Delozier, PHD

CEO

William Flickinger

Manufacturing Engineer

Lauren Gonzalez

Director of Product Development

Keith Grafmeyer

Production Manager

Addison Hocter

Office Manager

Ross LaMarca

Software Engineer

Kevin Libertowski

Clinical Engineering Manager

Adrianna Baiera

Software Engineering Manager

Brian Beckrest

UX/UI Designer

Tyler Blackiston

Infrastructure Engineer

Greg Delozier, PHD

CEO

William Flickinger

Manufacturing Engineer

Lauren Gonzalez

Director of Product Development

Keith Grafmeyer

Production Manager

Addison Hocter

Office Manager

Ross LaMarca

Software Engineer

Kevin Libertowski

Scientific Advisory Board

Our SAB consists of leading pulmonologists from around the country from world-class institutions.  They provide the VisionAir Team with clinical insights that only the most innovative physicians in the space can offer.  With their guidance, VisionAir is able to align their engineering and product development with the pulmonary needs of today and tomorrow.

Inventor and Head of Scientific Advisory Board
Dr. Thomas Gildea, MD, FCCP, FACP

Thomas Robert Gildea, MD, FCCP, FACP was appointed to Cleveland Clinic in 2003 to Department of Pulmonary Allergy and Critical Care Medicine & Transplant Center and is the Section Head of Bronchology in the Respiratory Institute, leading a team of dedicated Interventional Pulmonologists.  He has been board-certified in internal medicine, pulmonary disease and critical care medicine.

He has advanced training in interventional and advanced diagnostic bronchoscopy, which was part of his fellowship training at Cleveland Clinic. His clinical interests span the realm of advanced lung diseases, including lung volume reduction, lung transplantation, pulmonary arterial hypertension and is most focused on advanced diagnostic and therapeutic bronchoscopy.

Dr. Gildea was the first physician in North America to perform electromagnetic navigation bronchoscopy. He was given an Innovator Award at Cleveland Clinic in 2006 with his team proposing a novel device for a bronchoscopy needle-delivered fiducial lung implant. He has been named one of the Best Doctors in America since 2007. He also received a physician development award by the AlphaOne Foundation to study lung function changes after lung transplantation. In 2010 he completed a Master's degree at Case Western Reserve in Clinical Research. He was granted an NIH-NCAI grant for the initial work to form VisionAir Solutions around his idea for patient-specific airway stenting.

An invited lecturer at national and international medical meetings, Dr. Gildea is a recognized expert in the field of interventional pulmonary medicine. In addition to leading the VisionAir Solutions SAB, Dr. Gildea serves on advisory boards for several medical device companies and on several boards and committees of national specialty societies.

Member of Scientific Advisory Board
Dr. Andrew Haas
Member of Scientific Advisory Board
Dr. Ryan Kern
Member of Scientific Advisory Board
Dr. Bill Krimsky

VisionAir 3D Stent Availability

VisionAir 3D Stents are currently available from 20+ institutions in the United States. We are actively expanding our affiliated institutions to give more pulmonologists & patients the opportunity to experience a better solution for interventional airway treatment.